Anna Kołodziej

Profesor UMW

Uniwersytet Medyczny im Piastów Śląskich we Wrocławiu

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Immunology Immunology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Anna Kołodziej is a Professor at the Uniwersytet Medyczny im Piastów Śląskich we Wrocławiu in Poland. Her research primarily focuses on bladder cancer, specifically the management of patients with lymph node invasion, the impact of BCG immunotherapy, and the role of genetic polymorphisms in treatment outcomes. Recent publications include analyses of clinical outcomes in non-muscle-invasive bladder cancer and systematic reviews on management strategies for bladder tumors.

Articles (8)

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Wojciech Krajewski

Wroclaw Medical University

POLAND

View details

jan adamowicz

Nicolaus Copernicus University

POLAND

View details

Anna Tomkiewicz

Ludwik Hirszfeld Institute of Immunology and Experimental Therapy

POLAND

View details

Aleksandra Zdrojowy-Wełna

Medical University of Silesia

POLAND

View details

Joanna Chorbińska

Uniwersytecki Szpital Kliniczny im Jana Mikulicza-Radeckiego we Wroclawiu

POLAND

View details

Magdalena Łyko

Wroclaw Medical University

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anna Kołodziej

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Management of Bladder Cancer Patients with Clinical Evidence of Lymph Node Invasion (cN+)

Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes.

Management of Intradiverticular Bladder Tumours: A Systematic Review

Polymorphisms of genes encoding cytokines predict the risk of high-grade bladder cancer and outcomes of BCG immunotherapy.

Restaging transurethral resection of bladder tumours after BCG immunotherapy induction in patients with T1 non-muscle-invasive bladder cancer might not be associated with oncologic benefit

Analysis of age influence on oncological results and toxicity of BCG immunotherapy in non-muscle invasive bladder cancer

Clinical outcomes and survival differences between primary, secondary and concomitants carcinoma in situ of urinary bladder treated with BCG immunotherapy

Combination of histological and molecular data for improving outcome prediction in non-muscle invasive bladder cancer - narrative review

Collaborators (6)

Wojciech Krajewski

jan adamowicz

Anna Tomkiewicz

Aleksandra Zdrojowy-Wełna

Joanna Chorbińska

Magdalena Łyko

Make your next move.